| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000029397 |
| Receipt No. | R000033595 |
| Scientific Title | Relationship of coronary culprit lesion morphology and thrombus grade in patients with acute coronary syndrome |
| Date of disclosure of the study information | 2017/10/03 |
| Last modified on | 2020/04/05 (Ver. 3) |
| Basic information | ||
| Public title | Relationship of coronary culprit lesion morphology and thrombus grade in patients with acute coronary syndrome | |
| Acronym | Coronary culprit lesion morphology and thrombus grade in ACS | |
| Scientific Title | Relationship of coronary culprit lesion morphology and thrombus grade in patients with acute coronary syndrome | |
| Scientific Title:Acronym | Coronary culprit lesion morphology and thrombus grade in ACS | |
| Region |
|
|
| Condition | ||
| Condition | acute coronary syndrome | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the relationship of coronary culprit lesion morphology and thrombus grade in patients with acute coronary syndrome |
| Basic objectives2 | Others |
| Basic objectives -Others | To investigate the relationship of coronary culprit lesion morphology and visible or pathological aspirated thrombus characteristics in patients with acute coronary syndrome
To investigate major adverse cardiovascular and cerebrovascular event rate during one year between ACS patients with plaque rupture and non-plaque rupture, high thrombus and low thrombus burden or red and no-red thrombus |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Relationship of coronary culprit lesion morphology (plaque rupture and non-plaque rupture) and TIMI thrombus grade in patients with acute coronary syndrome |
| Key secondary outcomes | Relationship of coronary culprit lesion morphology (plaque rupture and non-plaque rupture) and visible or pathological aspirated thrombus characteristics in patients with acute coronary syndrome
Major adverse cardiovascular and cerebrovascular event rate during one year between ACS patients with plaque rupture and non-plaque rupture, high thrombus and low thrombus burden or red and no-red thrombus |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1. The group evaluated coronary culprit lesion morphology as plaque rupture by the imaging modalities
2. The group evaluated thrombus grade as high thrombus burden by coronary angiography 3. The group evaluated aspirated thrombus as visual or pathological red thrombus |
|
| Interventions/Control_2 | 1. The group evaluated coronary culprit lesion morphology as non-plaque rupture by the imaging modalities
2. The group evaluated thrombus grade as low thrombus burden by coronary angiography 3. The group evaluated aspirated thrombus as visual or pathological no or little red thrombus |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients with de novo acute coronary syndrome (ACS) within 24 hours after symptom onset(unstable angina pectoris, non-ST elevation myocardial infarction and ST-elevation myocardial infarction)
2. ACS patients performed emergent coronary angiography and primary percutaneous coronary intervention 3. ACS patients evaluated coronary culprit lesion morphology by the imaging modalities |
|||
| Key exclusion criteria | 1. Patients with ACS exceeding 24 hours after symptom onset
2. ACS patients with variant angina, stent restenosis or bypass graft failure 3. ACS patients not evaluated or difficult to evaluate coronary culprit lesion morphology by the imaging modalities 4. Inadequate patients by phisician's discresion |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tsuyama Chuo Hospital | ||||||
| Division name | Department of Cardiology | ||||||
| Zip code | 708-0841 | ||||||
| Address | 1756, Kawasaki, Tsuyama-city, Okayama | ||||||
| TEL | 0868218111 | ||||||
| kei.yunoki@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tsuyama Chuo Hospital | ||||||
| Division name | Department of Cardiology | ||||||
| Zip code | 708-0841 | ||||||
| Address | 1756, Kawasaki, Tsuyama-city, Okayama | ||||||
| TEL | 0868218111 | ||||||
| Homepage URL | http://www.tch.or.jp/clinical_research.html | ||||||
| kei.yunoki@gmail.com | |||||||
| Sponsor | |
| Institute | Tsuyama Chuo Hospital
Department of Cardiology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tsuyama Chuo Hospital
Department of Cardiology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Department of Cardiology, Tsuyama Chuo Hospital |
| Address | 1756, Kawasaki, Tsuyama-city, Okayama |
| Tel | 0868-21-8111 |
| ando11@tch.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033595 |